GALNT2 anticorps (AA 26-53) (HRP)

N° du produit ABIN1897453

Détail du produit anti-GALNT2 anticorps (HRP)

Antigène: GALNT2 (UDP-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 2 (GalNAc-T2) (GALNT2))

Épitope: AA 26-53

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp GALNT2 est conjugé à/à la HRP

Application: Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Flow Cytometry (FACS)

Specificité: This GALNT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 26-53 amino acids from the N-terminal region of human GALNT2.

Purification: Affinity purified

Isotype: IgG

Information d'application

Indications d'application: Approved: ELISA, Flo, IHC, WB

Usage: The applications listed have been tested for the base form of this product. Alternate forms, such as conjugated, azide-free, or ready-to-use, have not been tested.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: PBS, no preservatives added

Agent conservateur: Without preservative

Conseil sur la manipulation: Aliquot to avoid repeated freezing and thawing.

Stock: 4 °C,-20 °C

Stockage commentaire: Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.

Date de péremption: 6 months

Détails sur GALNT2

Antigène: GALNT2 (UDP-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 2 (GalNAc-T2) (GALNT2))

Autre désignation: GALNT2 (GALNT2 Produits)

Synonymes: anticorps GalNAc-T2, anticorps AI480629, anticorps im:7140357, anticorps si:dkey-162b3.1, anticorps polypeptide N-acetylgalactosaminyltransferase 2, anticorps UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2, anticorps Galnt2, anticorps GALNT2, anticorps galnt2

Sujet: Name/Gene ID: GALNT2

Synonyms: GALNT2, GalNAc-T2, Pp-GaNTase 2, UDP-GalNAc transferase 2

ID gène: 2590

Pathways: Production of Molecular Mediator of Immune Response